Paper19258943
The fallopian tube: primary site of most pelvic high-grade serous carcinomas.
Salvador S and 5 others. Int J Gynecol Cancer, 2009. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Papers, record 19258943. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19258943
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Fallopian Tube Neoplasms | Major topic |
| Neoplasms, Cystic, Mucinous, and Serous | Major topic |
| Ovarian Neoplasms | Major topic |
| Pelvic Neoplasms | Major topic |
| Contraceptives, Oral, Hormonal | |
| Female | |
| Genes, BRCA1 | |
| Humans | |
| Hysterectomy | |
| Infertility, Female | |
| Inflammation | |
| Parity | |
| Pregnancy | |
| Risk Factors | |
| Sterilization, Tubal |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41419662 | RAS/PI3K pathway mutations sensitise epithelial ovarian cancer cells to a PARP/NAMPT inhibitor combination. | Commun Biol | 2025 | https://conductscience.org/library/papers/41419662 | PubMed |
| 37760583 | Primary Retroperitoneal Carcinomas: New Insights into Pathogenesis and Clinical Management in Comparison with Ovarian Carcinomas and Carcinoma of Unknown Primary. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760583 | PubMed |
| 37672283 | Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review. | JAMA Surg | 2023 | https://conductscience.org/library/papers/37672283 | PubMed |
| 36688720 | Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. | J Natl Cancer Inst | 2023 | https://conductscience.org/library/papers/36688720 | PubMed |
| 36072240 | Review of the literature on combined oral contraceptives and cancer. | Ecancermedicalscience | 2022 | https://conductscience.org/library/papers/36072240 | PubMed |
| 35719320 | Etiopathogenesis of ovarian cancer. An inflamm-aging entity? | Gynecol Oncol Rep | 2022 | https://conductscience.org/library/papers/35719320 | PubMed |
| 35280443 | Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes. | Dis Markers | 2022 | https://conductscience.org/library/papers/35280443 | PubMed |
| 34834467 | Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature. | J Pers Med | 2021 | https://conductscience.org/library/papers/34834467 | PubMed |
| 34325771 | A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus. | Comp Med | 2021 | https://conductscience.org/library/papers/34325771 | PubMed |
| 34284794 | Comparing options for females seeking permanent contraception in high resource countries: a systematic review. | Reprod Health | 2021 | https://conductscience.org/library/papers/34284794 | PubMed |
| 33922503 | Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33922503 | PubMed |
| 33312883 | Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes. | World J Clin Oncol | 2020 | https://conductscience.org/library/papers/33312883 | PubMed |
| 32832298 | Prophylactic Bilateral Salpingo-oophorectomy in BRCA2 Mutation with Incidental Finding of Serous Tubal Intraepithelial Carcinoma (STIC) and Subsequent Diagnosis of Primary Peritoneal Carcinoma (PPC): A Case Report and Review of Current Literature. | Cureus | 2020 | https://conductscience.org/library/papers/32832298 | PubMed |
| 32552764 | Organoid technology in female reproductive biomedicine. | Reprod Biol Endocrinol | 2020 | https://conductscience.org/library/papers/32552764 | PubMed |
| 32098383 | Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis-Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/32098383 | PubMed |
| 30275673 | Trends of Opportunistic Salpingectomy. | JSLS | 2018 | https://conductscience.org/library/papers/30275673 | PubMed |
| 29656331 | Survey of pelvic reconstructive surgeons on performance of opportunistic salpingectomy at the time of pelvic organ prolapse repair. | Int Urogynecol J | 2019 | https://conductscience.org/library/papers/29656331 | PubMed |
| 29594039 | Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer. | Front Oncol | 2018 | https://conductscience.org/library/papers/29594039 | PubMed |
| 28639753 | Screening for ovarian cancer: imaging challenges and opportunities for improvement. | Ultrasound Obstet Gynecol | 2018 | https://conductscience.org/library/papers/28639753 | PubMed |
| 28357377 | Chlamydia trachomatis Genital Infections. | Microb Cell | 2016 | https://conductscience.org/library/papers/28357377 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19258943
GET https://conductscience.org/api/papers/v1/19258943/cited_by?page=2